The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta

Journal of Neurosurgery
H XiaoT Mapstone


Levels of protein kinase C (PKC) isoforms in eight human glioblastoma cell lines and two normal human glial cell cultures were determined. Earlier studies identified PKC-alpha and PKC-gamma in these cell lines but PKC-beta was not present. In this study, PKC-epsilon and PKC-zeta are demonstrated immunologically in these cell lines and also in two normal human glial cell cultures. Protein kinase C-delta was not present. When levels of the four isoforms in the tumor cells were compared to levels in the normal cells, no increase was observed in PKC-alpha or PKC-gamma, but PKC-epsilon was elevated three to 30 times in six of the eight tumors, and PKC-zeta was elevated approximately two times in all of the tumors. Incubation of cell line A172 with phorbol ester for 6 hours resulted in a 48-fold maximum increase in the nuclear PKC-epsilon and a sevenfold increase in the plasma membrane fraction with no change in the cytoplasmic fraction. A similar incubation for 4 hours produced a 0.5- to onefold increase of PKC-zeta in cytoplasmic, nuclear, and plasma membrane fractions. Other researchers have shown that overexpression of PKC-epsilon in fibroblasts results in tumorigenesis, and that blocking PKC-zeta function inhibits deoxyribonucle...Continue Reading


Jan 1, 1992·Glia·A Misra-PressD A Goldthwait
Dec 15, 1992·Cancer·H H WangM E Kadin
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K OgitaY Nishizuka
Apr 1, 1992·The Journal of Cell Biology·W C WetselY A Hannun
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H KoideY Nishizuka
Sep 15, 1991·European Journal of Biochemistry·A R Olivier, P J Parker
Jan 1, 1990·Neuroscience Letters·S ShimosawaH Hidaka
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·Y OnoY Nishizuka
Oct 6, 1989·JAMA : the Journal of the American Medical Association·Y Nishizuka
Aug 1, 1993·Molecular and Cellular Biology·M T Diaz-MecoJ Moscat

❮ Previous
Next ❯


Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·K K ChoM L Rosenblum
Jun 1, 1997·Antisense & Nucleic Acid Drug Development·R I Glazer
Jul 17, 2014·International Immunopharmacology·Lisheng GeMartin R Jadus
Aug 17, 2010·Neuroimaging Clinics of North America·Eudocia C Quant, Patrick Y Wen
Nov 18, 2017·International Journal of Molecular Sciences·Shailaja Mahajan-ThakurBernhard H Rauch
Feb 15, 2018·BMC Cancer·Ewa TotonMaria Rybczynska
Jun 7, 2005·Expert Opinion on Therapeutic Targets·Patrick M Martin, Isa M Hussaini
Nov 14, 2018·Journal of Cellular Physiology·Lei TianQingzhang Li
Sep 24, 2002·The Journal of Biological Chemistry·Bakhrom K BerdievDale J Benos
Apr 10, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Nidia AlvarezPatrice Le Pape
Aug 11, 2000·Applied Immunohistochemistry & Molecular Morphology : AIMM·R KorenS R Sampson
Mar 31, 2005·The Journal of Pharmacology and Experimental Therapeutics·Brian E ReeseJong Yun
Nov 1, 1995·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·G H BaltuchV W Yong
May 30, 2008·International Journal of Cancer. Journal International Du Cancer·Angus J CameronPeter J Parker

❮ Previous
Next ❯

Methods Mentioned

protein gel blot
protein assay

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.